EconPapers    
Economics at your fingertips  
 

Monoclonal antibody levels and protection from COVID-19

Eva Stadler, Martin T. Burgess, Timothy E. Schlub, Shanchita R. Khan, Khai Li Chai, Zoe K. McQuilten, Erica M. Wood, Mark N. Polizzotto, Stephen J. Kent, Deborah Cromer, Miles P. Davenport () and David S. Khoury ()
Additional contact information
Eva Stadler: University of New South Wales
Martin T. Burgess: University of New South Wales
Timothy E. Schlub: University of Sydney
Shanchita R. Khan: University of New South Wales
Khai Li Chai: Monash University
Zoe K. McQuilten: Monash University
Erica M. Wood: Monash University
Mark N. Polizzotto: The Australian National University
Stephen J. Kent: University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Deborah Cromer: University of New South Wales
Miles P. Davenport: University of New South Wales
David S. Khoury: University of New South Wales

Nature Communications, 2023, vol. 14, issue 1, 1-9

Abstract: Abstract Multiple monoclonal antibodies have been shown to be effective for both prophylaxis and therapy for SARS-CoV-2 infection. Here we aggregate data from randomized controlled trials assessing the use of monoclonal antibodies (mAb) in preventing symptomatic SARS-CoV-2 infection. We use data on the in vivo concentration of mAb and the associated protection from COVID-19 over time to model the dose-response relationship of mAb for prophylaxis. We estimate that 50% protection from COVID-19 is achieved with a mAb concentration of 96-fold of the in vitro IC50 (95% CI: 32—285). This relationship provides a tool for predicting the prophylactic efficacy of new mAb and against SARS-CoV-2 variants. Finally, we compare the relationship between neutralization titer and protection from COVID-19 after either mAb treatment or vaccination. We find no significant difference between the 50% protective titer for mAb and vaccination, although sample sizes limited the power to detect a difference.

Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/s41467-023-40204-1 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-40204-1

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-023-40204-1

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-40204-1